i3 Innovus Biographies

Deborah Marshall, PhD, MHSA is the Canada Research Chair of Health Services and Systems Research and Associate Professor in the Department of Community Health Sciences, University of Calgary and the Director of Health Technology Assessment at the Alberta Bone Joint Health Institute. She also holds a faculty position as an Assistant Professor in the Department of Clinical Epidemiology and Biostatistics at the Centre for Evaluation of Medicines at McMaster University. Previously, Dr. Marshall held the role of Vice President, Global Health Economics and Outcomes Research at i3 Innovus. Dr. Marshall joined i3 Innovus in 2000 and during her tenure, she managed numerous global health economic projects including prospective studies, cost-effectiveness models for a variety of products in the areas of osteoarthritis, blood screening, infectious disease, cardiac disease and cancer. Her peer-reviewed research funded by the Canadian Institutes of Health Research and the National Institute of Health are focused in the area of measuring patient preferences, pharmacogenomics and cost-effectiveness modeling in cancer. Dr. Marshall’s academic training includes a PhD from the School of Public Health at the University of North Carolina, Chapel Hill as an Alberta Heritage Foundation for Medical Research Scholar, an MSc in Health Services Research (University of Alberta) and a BSc in Biochemistry (University of Toronto). This training has been applied in a number of government, academic and industry research settings commissioning, conducting and authoring evaluations of various health technologies. This included working and directing research projects at national technology assessment agencies in Canada (CCOHTA–the Canadian Coordinating Agency for Health Technology Assessment) and Sweden (SBU - the Swedish Council on Technology Assessment in Health Care). Subsequently, Dr. Marshall was responsible for the design and analysis of health outcome and economic research studies for developing technologies at Bayer Diagnostics in California. Dr. Marshall is an active member of ISPOR, chaired the clinical working group of the Task Force on Real World Data and is a member of the Patient Preferences Special Interest Group. She is also a member of the CADTH/National Cancer Institute of Canada Working Group to develop cancer-specific economic guidelines.